Sort
10,766 grants matching “checkpoint inhibitor”
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$681,410Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
The Transmembrane Protein Disulfide Isomerase TMX1 Negatively Regulates Thrombosis
$681,384David W Essex · Temple Univ Of The Commonwealth · R01 · FY2024 · HL
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
$681,198Yaqing Zhang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Radiation-induced translational control of gene expression
$681,047Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$680,864Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Analyses of human T regulatory cells
$680,834Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Novel regulatory mechanisms and agonists of STING
$680,598Xuewu Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Novel regulatory mechanisms and agonists of STING
$680,598Xuewu Zhang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Targeting FGFR Alterations in Gastroesophageal Cancer
$680,532Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2025 · CA
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
$680,292Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
Drug eluting injectable biomaterials for next generation chemoembolization
$680,198Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2021 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$680,126Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Evaluating and Optimizing Novel nSMase2 Inhibitors in the Treatment of Cancers
$680,034Robert H Blelloch · University Of California, San Francisco · R01 · FY2025 · CA
Variation in tumor-associated immune profiles and colorectal cancer outcomes
$679,508Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Enabling the therapeutic delivery for spinal cord glioma by epidural light-guided modulation of blood-spinal-cord barrier
$679,176Zhenpeng Qin · University Of Texas Dallas · R01 · FY2025 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer
$679,154Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Immunoregulatory role of lung-resident club cell factors in lung cancer
$679,154Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$678,954Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2019 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$678,731Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE
Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy
$678,605Weizhou Zhang · University Of Florida · R01 · FY2024 · CA
Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma
$678,399Carrie Daniel-Macdougall · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Antidepressant regulation of PDAC
$677,974Valerie Marie Weaver · University Of California, San Francisco · U01 · FY2025 · CA
Targeting Non Viral Markers of HIV Persistence
$677,623Timothy Jensen Henrich · University Of California, San Francisco · R01 · FY2021 · AI
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer
$677,533Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Development of novel human Fab probes for PET imaging of macrophages
$677,520Bernadette Marquez-Nostra · Yale University · R01 · FY2022 · EB